Patent attorney Jay Halt explains how medtech companies should align IP strategy with FDA compliance to avoid unenforceable patents and regulatory issues.

Change is coming, but how quickly depends on the availability of data and when chipmakers are confident enough to let AI take over.

Today (the 23rd) at CEDEC 2026, Capcom presented a session on the industry-trending topic of AI in game development, using ...

Pop-up FAST channels have evolved from short-term promotional plays into a viable streaming market-entry strategy, enabled by cloud playout technology that cuts the launch timeline from months to days ...

Andriy Blokhin has 5+ years of professional experience in public accounting, personal investing, and as a senior auditor with Ernst & Young. Erika Rasure is globally-recognized as a leading consumer ...

The bottleneck in a mature SOC is rarely analyst triage; rather, it is the detection-engineering team's ability to keep the ...

As the use of generative AI (“gen AI”) platforms becomes ubiquitous in both legal practice and business operations, courts are confronting ...